CN108524886A - 一种手足癣药贴及其制备方法 - Google Patents
一种手足癣药贴及其制备方法 Download PDFInfo
- Publication number
- CN108524886A CN108524886A CN201810520185.7A CN201810520185A CN108524886A CN 108524886 A CN108524886 A CN 108524886A CN 201810520185 A CN201810520185 A CN 201810520185A CN 108524886 A CN108524886 A CN 108524886A
- Authority
- CN
- China
- Prior art keywords
- tinea
- hands
- feet
- drug paste
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims description 83
- 208000002474 Tinea Diseases 0.000 title claims description 59
- 241000130764 Tinea Species 0.000 title claims description 58
- 229940079593 drug Drugs 0.000 title claims description 51
- 238000002360 preparation method Methods 0.000 title claims description 24
- 210000002683 foot Anatomy 0.000 claims description 75
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 36
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 34
- 239000000203 mixture Substances 0.000 claims description 28
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 claims description 26
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 claims description 25
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 claims description 25
- 201000004647 tinea pedis Diseases 0.000 claims description 23
- 239000000341 volatile oil Substances 0.000 claims description 23
- 241000234314 Zingiber Species 0.000 claims description 22
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 22
- 235000008397 ginger Nutrition 0.000 claims description 22
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims description 19
- 239000005864 Sulphur Substances 0.000 claims description 19
- 241000723353 Chrysanthemum Species 0.000 claims description 18
- 235000007516 Chrysanthemum Nutrition 0.000 claims description 18
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 17
- 239000002994 raw material Substances 0.000 claims description 17
- 229960004889 salicylic acid Drugs 0.000 claims description 17
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 16
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 16
- 240000001851 Artemisia dracunculus Species 0.000 claims description 16
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 16
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 16
- 241000951473 Schizonepeta Species 0.000 claims description 16
- 239000001138 artemisia absinthium Substances 0.000 claims description 16
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 16
- 235000012907 honey Nutrition 0.000 claims description 15
- 241000208140 Acer Species 0.000 claims description 14
- 241000931705 Cicada Species 0.000 claims description 14
- 239000012065 filter cake Substances 0.000 claims description 14
- 241000522620 Scorpio Species 0.000 claims description 13
- 239000009490 scorpio Substances 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 13
- 238000009835 boiling Methods 0.000 claims description 12
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000000227 grinding Methods 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 238000001291 vacuum drying Methods 0.000 claims description 12
- 238000002156 mixing Methods 0.000 claims description 11
- 238000005119 centrifugation Methods 0.000 claims description 7
- 239000011248 coating agent Substances 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 6
- 238000001816 cooling Methods 0.000 claims description 6
- 239000008367 deionised water Substances 0.000 claims description 6
- 229910021641 deionized water Inorganic materials 0.000 claims description 6
- 238000004821 distillation Methods 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 6
- 239000008236 heating water Substances 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 238000003860 storage Methods 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 4
- 241000219000 Populus Species 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 26
- 230000000694 effects Effects 0.000 description 16
- 241000233866 Fungi Species 0.000 description 13
- 210000003371 toe Anatomy 0.000 description 13
- 208000003251 Pruritus Diseases 0.000 description 8
- 230000000857 drug effect Effects 0.000 description 8
- 230000006870 function Effects 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 201000010099 disease Diseases 0.000 description 6
- 241001480043 Arthrodermataceae Species 0.000 description 5
- 206010067197 Tinea manuum Diseases 0.000 description 5
- 230000037304 dermatophytes Effects 0.000 description 5
- 239000002674 ointment Substances 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 241000256844 Apis mellifera Species 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- 206010017533 Fungal infection Diseases 0.000 description 4
- 208000031888 Mycoses Diseases 0.000 description 4
- 230000001139 anti-pruritic effect Effects 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 206010037844 rash Diseases 0.000 description 4
- 230000001954 sterilising effect Effects 0.000 description 4
- 208000010195 Onychomycosis Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 229940121375 antifungal agent Drugs 0.000 description 3
- 230000003628 erosive effect Effects 0.000 description 3
- -1 fatty acid sodium salt Chemical class 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 244000045947 parasite Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 239000011505 plaster Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000000452 restraining effect Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 229960002722 terbinafine Drugs 0.000 description 3
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 description 3
- 201000005882 tinea unguium Diseases 0.000 description 3
- XMVQWNRDPAAMJB-UHFFFAOYSA-N (+)-13-Cyclopent-2-enyl-tridecansaeure Natural products OC(=O)CCCCCCCCCCCCC1CCC=C1 XMVQWNRDPAAMJB-UHFFFAOYSA-N 0.000 description 2
- XMVQWNRDPAAMJB-QGZVFWFLSA-N (S)-chaulmoogric acid Chemical compound OC(=O)CCCCCCCCCCCC[C@H]1CCC=C1 XMVQWNRDPAAMJB-QGZVFWFLSA-N 0.000 description 2
- YFVGIJBUXMQFOF-PJOVQGMDSA-N 5-hydroxy-2-(4-methoxyphenyl)-7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one Chemical compound C1=CC(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 YFVGIJBUXMQFOF-PJOVQGMDSA-N 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 208000007163 Dermatomycoses Diseases 0.000 description 2
- 206010048768 Dermatosis Diseases 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000558306 Gynocardia odorata Species 0.000 description 2
- YFVGIJBUXMQFOF-SAXLCNSLSA-N Linarin Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4ccc(OC)cc4)Oc3c2)O1)[C@H]1[C@@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 YFVGIJBUXMQFOF-SAXLCNSLSA-N 0.000 description 2
- 206010028813 Nausea Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000037273 Pathologic Processes Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 208000024780 Urticaria Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- 230000000843 anti-fungal effect Effects 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 238000007654 immersion Methods 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- IYRMWMYZSQPJKC-UHFFFAOYSA-N kaempferol Chemical compound C1=CC(O)=CC=C1C1=C(O)C(=O)C2=C(O)C=C(O)C=C2O1 IYRMWMYZSQPJKC-UHFFFAOYSA-N 0.000 description 2
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000002266 mite infestation Diseases 0.000 description 2
- 230000008693 nausea Effects 0.000 description 2
- 229940127249 oral antibiotic Drugs 0.000 description 2
- 230000009054 pathological process Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- PVNIQBQSYATKKL-UHFFFAOYSA-N tripalmitin Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCC PVNIQBQSYATKKL-UHFFFAOYSA-N 0.000 description 2
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- BLSQLHNBWJLIBQ-OZXSUGGESA-N (2R,4S)-terconazole Chemical compound C1CN(C(C)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2N=CN=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 BLSQLHNBWJLIBQ-OZXSUGGESA-N 0.000 description 1
- CUXYLFPMQMFGPL-UHFFFAOYSA-N (9Z,11E,13E)-9,11,13-Octadecatrienoic acid Natural products CCCCC=CC=CC=CCCCCCCCC(O)=O CUXYLFPMQMFGPL-UHFFFAOYSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- SRELFLQJDOTNLJ-HNNXBMFYSA-N (R)-hydnocarpic acid Chemical compound OC(=O)CCCCCCCCCC[C@@H]1CCC=C1 SRELFLQJDOTNLJ-HNNXBMFYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 208000010470 Ageusia Diseases 0.000 description 1
- 208000028185 Angioedema Diseases 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 239000003390 Chinese drug Substances 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- UBSCDKPKWHYZNX-UHFFFAOYSA-N Demethoxycapillarisin Natural products C1=CC(O)=CC=C1OC1=CC(=O)C2=C(O)C=C(O)C=C2O1 UBSCDKPKWHYZNX-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000035874 Excoriation Diseases 0.000 description 1
- 206010016717 Fistula Diseases 0.000 description 1
- 208000002655 Foot Dermatoses Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- SRELFLQJDOTNLJ-UHFFFAOYSA-N Hydnocarpic acid Natural products OC(=O)CCCCCCCCCCC1CCC=C1 SRELFLQJDOTNLJ-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020852 Hypertonia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 241000220645 Leonotis nepetifolia Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 240000000203 Salix gracilistyla Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 241000893966 Trichophyton verrucosum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- NDTNEAIKTSZYCF-XWNHBAMRSA-N [(1R,4aR,4bR,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carbonyl] (1R,4aR,4bR,10aR)-1,4a-dimethyl-7-propan-2-yl-2,3,4,4b,5,6,10,10a-octahydrophenanthrene-1-carboxylate Chemical compound C([C@@H]1[C@@]2(C)CCC3)CC(C(C)C)=CC1=CC[C@H]2[C@]3(C)C(=O)OC(=O)[C@]1(C)CCC[C@@]2(C)[C@H]1CC=C1C=C(C(C)C)CC[C@@H]12 NDTNEAIKTSZYCF-XWNHBAMRSA-N 0.000 description 1
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 description 1
- QBYFCXBVWQQXFH-UHFFFAOYSA-N acaciin Natural products COc1ccc(cc1)C2=CC(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4OC6OCC(O)C(O)C6O)cc3O2 QBYFCXBVWQQXFH-UHFFFAOYSA-N 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000003470 adrenal cortex hormone Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000019666 ageusia Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- CUXYLFPMQMFGPL-SUTYWZMXSA-N all-trans-octadeca-9,11,13-trienoic acid Chemical compound CCCC\C=C\C=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-SUTYWZMXSA-N 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- 108010065394 aminopherase Proteins 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 238000009360 aquaculture Methods 0.000 description 1
- 244000144974 aquaculture Species 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 208000002352 blister Diseases 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000007799 cork Substances 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006356 dehydrogenation reaction Methods 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 230000003890 fistula Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- RFHAOTPXVQNOHP-UHFFFAOYSA-N fluconazole Chemical compound C1=NC=NN1CC(C=1C(=CC(F)=CC=1)F)(O)CN1C=NC=N1 RFHAOTPXVQNOHP-UHFFFAOYSA-N 0.000 description 1
- 229960004884 fluconazole Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 244000053095 fungal pathogen Species 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 235000008777 kaempferol Nutrition 0.000 description 1
- 230000003780 keratinization Effects 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- UXOUKMQIEVGVLY-UHFFFAOYSA-N morin Natural products OC1=CC(O)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)O)=C1 UXOUKMQIEVGVLY-UHFFFAOYSA-N 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 230000000926 neurological effect Effects 0.000 description 1
- 231100000189 neurotoxic Toxicity 0.000 description 1
- 230000002887 neurotoxic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 239000002795 scorpion venom Substances 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 206010040882 skin lesion Diseases 0.000 description 1
- 231100000444 skin lesion Toxicity 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960000580 terconazole Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229960001947 tripalmitin Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Insects & Arthropods (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Inorganic Chemistry (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种手足癣药贴及其制备方法,1)将艾草和菊花粉碎,沸水煎煮过滤浓缩,制得药剂Ⅰ;2)荆芥粉碎,搅拌蒸馏,离心静置,取上层油液,即得荆芥挥发油;3)将生姜、大枫子、蝉蜕和全蝎粉碎,浸泡过滤;干燥滤饼,得到药剂Ⅱ;4)将药剂Ⅰ、药剂Ⅱ和荆芥挥发油混合;水浴加热下,加入蜂蜜、水杨酸和硫磺,制得目标药剂;5)将目标药剂加入熔化的松香中,搅拌均匀,涂覆于牛皮纸上,自然冷却后即得到手足癣药贴。本发明制备方法制得的手足癣药贴,对多种致病的皮肤真菌都有很强的抑制作用,可有效抑制手足癣真菌的滋生;且具有攻毒杀虫止痒的功效,可加速透疹,使病理过程可以尽快消退;且治疗过程简单,无任何副作用,见效快,无复发。
Description
技术领域
本发明涉及医药领域,尤其涉及一种手足癣药贴及其制备方法。
背景技术
手足癣是手癣和足癣的总称,手癣是指发生在手掌和指间的皮肤癣菌感染,足癣是指发生于足跖部及趾间的皮肤癣菌感染。手足癣,系真菌感染引起,其皮肤损害往往是先单侧(即单脚或单手)发生,数周或数月后才感染到对侧。水疱主要出现在(指)趾腹和(指)趾侧,最常见于趾间,足底、手背亦可出现,为深在性小水疱,可逐渐融合成大疱。足癣的皮肤损害有一特点,即边界清楚,可逐渐向外扩展。因病情发展或搔抓,可出现糜烂、渗液,甚或细菌感染,出现脓疱等。妇女在妊娠期间,由于内分泌的变化,引起皮肤抵抗真菌感染的能力下降,易患足癣。肥胖者因趾间潮湿,汗液浸渍易患足癣。足部皮肤受外伤,破坏了皮肤的防御功能,也是诱发足癣的因素之一。糖尿病患者由于缺乏胰岛素导致物质代谢紊乱,皮肤含糖量增加导致抵抗力下降,也易患足癣。滥用抗生素,长期使用皮质类固醇激素和免疫抑制剂等,使皮肤正常菌群失调,也会增加足癣的易感性。足癣的发病还与生活习惯有关。有些人不注意足部清洁卫生和鞋袜的情况,为真菌提供了良好的孳生场所。
足癣是由致病性真菌引起的足部皮肤病,具有传染性。足癣在全世界广为流行,在热带和亚热带地区更为普遍。在我国,足癣的发病率也相当高。人的足底和趾间没有皮脂腺,从而缺乏抑制皮肤丝状真菌的脂肪酸,生理防御机能较差,而这些部位的皮肤汗腺却很丰富,出汗比较多,加之空气流通性差、局部潮湿温暖,有利于丝状真菌的生长。此外,足底部位皮肤角质层较厚,角质层中的角蛋白是真菌的丰富营养物质,有利于真菌的生长。
常见足癣的临床表现为脚趾间起水疱、脱皮或皮肤发白湿软,也可出现糜烂或皮肤增厚、粗糙、开裂,并可蔓延至足跖及边缘,剧痒。可伴局部化脓、红肿、疼痛,腹股沟淋巴结肿大,甚至形成小腿丹毒及蜂窝组织炎等继发感染。由于用手抓痒处,常传染至手而发生手癣(鹅掌风)。真菌在指(趾)甲上生长,则成甲癣(灰指甲)。真菌喜爱潮湿温暖的环境,夏季天热多汗,穿胶鞋、尼龙袜者更是为真菌提供了温床;冬季病情多好转,表现为皮肤开裂。有以下几种类型:一、水疱型:多发生在夏季,表现为趾间、足缘、足底出现米粒大小,深在性水疱,疏散或成群分布,疱壁较厚,内容清澈,不易破裂,相互融合形成多房性水疱,撕去疱壁,可见蜂窝状基底及鲜红色糜烂面,剧烈瘙痒。二、糜烂型:表现为局部表皮角质层浸软发白,由于走动时不断摩擦表皮脱落,露出鲜红色糜烂面;严重者趾缝间、趾腹与足底交界处皮肤均可累及,瘙痒剧烈,多发于第3、4、5趾缝间,常见于多汗者。三、鳞屑角化型:症状是足跖、足缘、足跟部皮肤脚趾增厚、粗糙、脱屑,鳞屑成片状或小点状,反复脱落。
常见治疗方法:一、用1∶8000高锰酸钾溶液湿敷,然后外用油剂或粉剂,待皮肤干燥后改用盐酸特比萘芬等霜剂或软膏;二、涂抹抗真菌药;三、口服抗生素,如特比萘芬、伊曲康唑、氟康唑等。
以上治疗方法具有如下缺陷:一、治疗过程复杂,且口服盐酸特比萘芬有如下不良反应:最常见的有胃肠道症状(胀满感、食欲不振、恶心、轻度腹痛及腹泻)或轻型的皮肤反应(皮疹、荨麻疹等);个别严重的皮肤反应病例(如Stevens-Johnson综合性、中毒性表皮坏死松解症)曾见报道,若发生进行性皮疹,则应停药;罕见味觉改变,包括味觉缺失,后者于停药后几周内可恢复;极个别病例发生肝胆功能不全。在遇到这些不良反应时必须停药,从而延误手足癣的治疗。二、涂抹抗真菌药,虽然没有太大副作用,但是里面含有一定量的激素,所以是不能长时间使用的,否则会形成激素依赖性皮炎,但是这类外用抗真菌药使用时间短对手足癣的治疗很有限,易复发。三、口服抗生素,会给身体带来很大的副作用,常见胃肠道不适,如厌食、恶心、腹痛和便秘,较少见的副作用包括头痛、可逆性氨基转移酶升高、月经紊乱、头晕和过敏反应(如瘙痒、红斑、风团和血管性水肿)。
发明内容
本发明的目的在于克服现有技术的不足,提供了一种手足癣药贴及其制备方法,以解决现有治疗方法中存在的治疗过程复杂、口服药物副作用大、外用药物治愈时间长、易复发等技术问题进行改进,本发明具有治疗过程简单,仅需外用药贴,无任何副作用,且见效快,治愈后不会再复发等特点。
本发明公开了以下技术方案;一种手足癣药贴,包括以下原料组分:艾草、荆芥、生姜、菊花、蜂蜜、水杨酸、大枫子、硫磺、蝉蜕、全蝎和松香。
进一步的,为了使各原料组分发挥最大的效用,各原料组分的重量份数为:
其中,各原料组分在本发明配方中的功效与作用如下:
艾草,具有抑菌杀菌的作用,对多种致病的皮肤真菌都有很强的抑制作用,可治疗多种皮肤病,在本方中加入艾草可有效抑制手足癣真菌的滋生。
荆芥,手足癣常伴有瘙痒症状,本方中加入荆芥可以利用其止痒的功效,并且加速透疹,使病理过程可以尽快消退。
生姜,别名有姜根、百辣云、勾装指、因地辛、炎凉小子、鲜生姜、蜜炙姜,姜的根茎(干姜)、栓皮(姜皮)、叶(姜叶)均可入药,因生姜具有显著抑制皮肤真菌的作用,在此方中加入生姜可更有效的杀灭引起手足癣的皮癣菌。
菊花,含挥发油,油中含菊醇、菊酮、α—蒎烯、樟脑、龙脑、樟烯等,尚含菊花内酯、菊花素A、刺槐甙、蒙花甙、菊甙、木犀草素,能祛风解毒,对疥疮、暗疮等疾病有很强的疗效。
蜂蜜,性味甘平,能补脾润肺,解毒矫味,多用于制补脾润肺止咳的药物,在本方中将蜂蜜与中药混合物Ⅳ搅拌乳化后能缓和药物的偏性,并与药物起到协同作用,增强疗效,以达到治疗目的。
水杨酸,具有杀灭真菌的作用。
大枫子,主要成分为大风子油酸、次大风子油酸、去氢大风子油酸的甘油酷,大风子烯酸,及少量油酸甘油酯和软脂酸甘油酯等,大风子油及其脂肪酸钠盐在试管内抗菌作用比酚强100倍以上,油的抑制作用不强,而脂肪酸钠盐的作用较强,大风子的水浸液在试管内对奥杜盎氏小芽胞癣菌有抑制作用;所含之棕桐酸具有镇静、解痉作用;本方中加入大风子,主要利用了其所含化学成分具有较强的抗菌杀菌的功效。
硫磺,是攻毒杀虫止痒的中药,可治疗痈肿疔疮、湿疹疥癣。
蝉蜕,可治麻疹不透,风疹瘙痒。
全蝎,含蝎毒,为一种类似蛇毒神经毒的蛋白质,并含三甲胺、甜菜碱、牛黄酸、软脂酸、硬脂酸、胆甾醇、卵磷脂及铵盐等,有攻毒、散结之效。
松香,主含松香酸酐,流离的松香酸,并含树脂烃及挥发油,如α及β—蒎烯,柠檬烯等,另含槲皮素,山柰酚的苷以及苦味物质,可祛风燥湿,拔毒排脓,生肌止痛。主治风湿痹痛,痈疽恶疮,瘰疬瘘症,疠风疥癣,白秃头疮,金疮折伤。
进一步的,为了使各原料组分在本发明制备的手足癣药贴中更好的发挥药效和作用,各原料组分的重量份数优选为:
本发明公开了一种制备以上手足癣药贴的方法,包括以下制备步骤:
1)称取艾草和菊花并混合粉碎处理,将碎末放入锅中用沸水煎煮,沸水煎煮2~3小时后,过滤,保留滤液;将滤液放入真空干燥箱中烘干处理,浓缩后得到药剂Ⅰ,备用;
2)称取荆芥并粉碎,倒入盛放有去离子水的三口烧瓶中,搅拌蒸馏,对馏出液离心处理,离心后静置,取上层油液,即得荆芥挥发油,备用;
3)将生姜、大枫子、蝉蜕和全蝎进行混合粉碎,粉碎成80~120目粉末,用温水浸泡3小时后,过滤;保留滤饼,并将滤饼放入烘箱中干燥处理,得到药剂Ⅱ;
4)将药剂Ⅰ和药剂Ⅱ混合,并向混合物中加入荆芥挥发油;水浴加热下,再向混合物中依次加入蜂蜜、水杨酸和硫磺,搅拌均匀后,保温静置24小时,得到目标药剂;
5)裁剪牛皮纸,并将松香放入坩埚中加热熔化,然后将目标药剂加入到松香中,搅拌均匀后,然后再将混合物涂覆于牛皮纸上,松香自然冷却后即得到手足癣药贴。
进一步的,为了使艾草和菊花中的有效成分被更好的提炼出来,同时,也为了避免因温度或压力过高使艾草和菊花的药效变性,步骤1)中真空干燥箱的温度控制在75℃,压力控制在-0.1~-0.05MPa。
进一步的,为了防止制得的荆芥挥发油挥发过快,影响药效,步骤2)中制得的荆芥挥发油需密闭、干燥存放。
进一步的,为了防止生姜、大枫子、蝉蜕和全蝎粉末因浸泡的温水温度过高,影响留取的滤饼中各组分的药效,步骤3)中温水的温度控制在45~55℃,为了使滤饼保持一定的干燥度同时不影响各组分药效,烘箱内的温度控制在85℃。
进一步的,为了促进药剂Ⅰ、药剂Ⅱ和荆芥挥发油更好的混合,同时为了避免水浴温度过高,使荆芥挥发油挥发过快影响药效,步骤4)中水浴温度控制在50~55℃,并且水杨酸和硫磺按照质量比1:1配比。
进一步的,为了使制得的药贴便于贴敷在患处,步骤5)中将混合物涂覆于牛皮纸上,混合物涂覆的厚度不超过1mm。
进一步的,为了使制得的药贴药效持续的更长久,步骤5)中制备好的手足癣药贴要放置于密闭、干燥、无菌的干燥器中保存。
本发明的制备方法制得的手足癣药贴具有如下有益效果:该手足癣药贴中的中药成分具有抑菌杀菌的作用,对多种致病的皮肤真菌都有很强的抑制作用,可治疗多种皮肤病,可有效抑制手足癣真菌的滋生;且具有攻毒杀虫止痒的功效,并且可加速透疹,使病理过程可以尽快消退;且该治疗过程简单,仅需外用药贴,无任何副作用,见效快,治愈后不会再复发等特点。
具体实施方式
下面对本发明的实施例作详细说明,本实施例在以本发明技术方案为前提下进行实施,给出了详细的实施方式和具体的操作过程,但本发明的保护范围不限于下述的实施例。
实施例1
实施例1公开了一种手足癣药贴,包括以下原料组分:艾草、荆芥、生姜、菊花、蜂蜜、水杨酸、大枫子、硫磺、蝉蜕、全蝎和松香。
其中,各原料组分的重量份数为:
本实施例公开了一种手足癣药贴的制备方法,包括以下制备步骤:
1)称取艾草和菊花并混合粉碎处理,将碎末放入锅中用沸水煎煮,沸水煎煮2小时后,过滤,保留滤液;将滤液放入真空干燥箱中烘干处理,浓缩后得到药剂Ⅰ,备用;
2)称取荆芥并粉碎,倒入盛放有去离子水的三口烧瓶中,搅拌蒸馏,对馏出液离心处理,离心后静置,取上层油液,即得荆芥挥发油,备用;
3)将生姜、大枫子、蝉蜕和全蝎进行混合粉碎,粉碎成80目粉末,用温水浸泡3小时后,过滤;保留滤饼,并将滤饼放入烘箱中干燥处理,得到药剂Ⅱ;
4)将药剂Ⅰ和药剂Ⅱ混合,并向混合物中加入荆芥挥发油;水浴加热下,再向混合物中依次加入蜂蜜、水杨酸和硫磺,搅拌均匀后,保温静置24小时,得到目标药剂;
5)裁剪牛皮纸,并将松香放入坩埚中加热熔化,然后将目标药剂加入到松香中,搅拌均匀后,然后再将混合物涂覆于牛皮纸上,松香自然冷却后即得到手足癣药贴。
其中,步骤1)中真空干燥箱的温度控制在75℃,压力控制在-0.1MPa。
其中,步骤2)中制得的荆芥挥发油需密闭、干燥存放。
其中,步骤3)中温水的温度控制在45℃,烘箱内的温度控制在85℃。
其中,步骤4)中水浴温度控制在50℃,并且水杨酸和硫磺按照质量比1:1配比。
其中,步骤5)中将混合物涂覆于牛皮纸上,混合物涂覆的厚度不超过1mm。
其中,步骤5)中制备好的手足癣药贴要放置于密闭、干燥、无菌的干燥器中保存。
实施例2
实施例2公开了一种手足癣药贴,包括以下原料组分:艾草、荆芥、生姜、菊花、蜂蜜、水杨酸、大枫子、硫磺、蝉蜕、全蝎和松香。
其中,各原料组分的重量份数为:
本实施例公开了一种手足癣药贴的制备方法,包括以下制备步骤:
1)称取艾草和菊花并混合粉碎处理,将碎末放入锅中用沸水煎煮,沸水煎煮2.5小时后,过滤,保留滤液;将滤液放入真空干燥箱中烘干处理,浓缩后得到药剂Ⅰ,备用;
2)称取荆芥并粉碎,倒入盛放有去离子水的三口烧瓶中,搅拌蒸馏,对馏出液离心处理,离心后静置,取上层油液,即得荆芥挥发油,备用;
3)将生姜、大枫子、蝉蜕和全蝎进行混合粉碎,粉碎成100目粉末,用温水浸泡3小时后,过滤;保留滤饼,并将滤饼放入烘箱中干燥处理,得到药剂Ⅱ;
4)将药剂Ⅰ和药剂Ⅱ混合,并向混合物中加入荆芥挥发油;水浴加热下,再向混合物中依次加入蜂蜜、水杨酸和硫磺,搅拌均匀后,保温静置24小时,得到目标药剂;
5)裁剪牛皮纸,并将松香放入坩埚中加热熔化,然后将目标药剂加入到松香中,搅拌均匀后,然后再将混合物涂覆于牛皮纸上,松香自然冷却后即得到手足癣药贴。
其中,步骤1)中真空干燥箱的温度控制在75℃,压力控制在-0.05MPa。
其中,步骤2)中制得的所述荆芥挥发油需密闭、干燥存放。
其中,步骤3)中温水的温度控制在50℃,烘箱内的温度控制在85℃。
其中,步骤4)中水浴温度控制在53℃,并且水杨酸和硫磺按照质量比1:1配比。
其中,步骤5)中将混合物涂覆于牛皮纸上,混合物涂覆的厚度不超过1mm。
其中,步骤5)中制备好的手足癣药贴要放置于密闭、干燥、无菌的干燥器中保存。
实施例3
实施例3公开了一种手足癣药贴,包括以下原料组分:艾草、荆芥、生姜、菊花、蜂蜜、水杨酸、大枫子、硫磺、蝉蜕、全蝎和松香。
其中,各原料组分的重量份数为:
本实施例公开了一种手足癣药贴的制备方法,包括以下制备步骤:
1)称取艾草和菊花并混合粉碎处理,将碎末放入锅中用沸水煎煮,沸水煎煮3小时后,过滤,保留滤液;将滤液放入真空干燥箱中烘干处理,浓缩后得到药剂Ⅰ,备用;
2)称取荆芥并粉碎,倒入盛放有去离子水的三口烧瓶中,搅拌蒸馏,对馏出液离心处理,离心后静置,取上层油液,即得荆芥挥发油,备用;
3)将生姜、大枫子、蝉蜕和全蝎进行混合粉碎,粉碎成90目粉末,用温水浸泡3小时后,过滤;保留滤饼,并将滤饼放入烘箱中干燥处理,得到药剂Ⅱ;
4)将药剂Ⅰ和药剂Ⅱ混合,并向混合物中加入荆芥挥发油;水浴加热下,再向混合物中依次加入蜂蜜、水杨酸和硫磺,搅拌均匀后,保温静置24小时,得到目标药剂;
5)裁剪牛皮纸,并将松香放入坩埚中加热熔化,然后将目标药剂加入到松香中,搅拌均匀后,然后再将混合物涂覆于牛皮纸上,松香自然冷却后即得到手足癣药贴。
其中,步骤1)中真空干燥箱的温度控制在75℃,压力控制在-0.05MPa。
其中,步骤2)中制得的所述荆芥挥发油需密闭、干燥存放。
其中,步骤3)中温水的温度控制在49℃,烘箱内的温度控制在85℃。
其中,步骤4)中水浴温度控制在52℃,并且水杨酸和硫磺按照质量比1:1配比。
其中,步骤5)中将混合物涂覆于牛皮纸上,混合物涂覆的厚度不超过1mm。
其中,步骤5)中制备好的手足癣药贴要放置于密闭、干燥、无菌的干燥器中保存。
实施例4
实施例4公开了一种手足癣药贴,包括以下原料组分:艾草、荆芥、生姜、菊花、蜂蜜、水杨酸、大枫子、硫磺、蝉蜕、全蝎和松香。
其中,各原料组分的重量份数为:
本实施例公开了一种手足癣药贴的制备方法,包括以下制备步骤:
1)称取艾草和菊花并混合粉碎处理,将碎末放入锅中用沸水煎煮,沸水煎煮3小时后,过滤,保留滤液;将滤液放入真空干燥箱中烘干处理,浓缩后得到药剂Ⅰ,备用;
2)称取荆芥并粉碎,倒入盛放有去离子水的三口烧瓶中,搅拌蒸馏,对馏出液离心处理,离心后静置,取上层油液,即得荆芥挥发油,备用;
3)将生姜、大枫子、蝉蜕和全蝎进行混合粉碎,粉碎成120目粉末,用温水浸泡3小时后,过滤;保留滤饼,并将滤饼放入烘箱中干燥处理,得到药剂Ⅱ;
4)将药剂Ⅰ和药剂Ⅱ混合,并向混合物中加入荆芥挥发油;水浴加热下,再向混合物中依次加入蜂蜜、水杨酸和硫磺,搅拌均匀后,保温静置24小时,得到目标药剂;
5)裁剪牛皮纸,并将松香放入坩埚中加热熔化,然后将目标药剂加入到松香中,搅拌均匀后,然后再将混合物涂覆于牛皮纸上,松香自然冷却后即得到手足癣药贴。
其中,步骤1)中真空干燥箱的温度控制在75℃,压力控制在-0.1MPa。
其中,步骤2)中制得的所述荆芥挥发油需密闭、干燥存放。
其中,步骤3)中温水的温度控制在55℃,烘箱内的温度控制在85℃。
其中,步骤4)中水浴温度控制在55℃,并且水杨酸和硫磺按照质量比1:1配比。
其中,步骤5)中将混合物涂覆于牛皮纸上,混合物涂覆的厚度不超过1mm。
其中,步骤5)中制备好的手足癣药贴要放置于密闭、干燥、无菌的干燥器中保存。
一、针对手足癣患者的临床试验。
1、试验对象:250例手足癣患者,男165例,女85例。
2、治疗方法
采用平行对照的原则将250例手足癣患者分为治疗组(实施例1~4共四组)和对照组(共一组),每组50例患者。
经统计学分析,各组患者性别、年龄、病程,程度分级等无显著性差异(P>0.05),具有可比性。
治疗组:用温热水浸泡患处10分钟擦干后,于患处粘贴本发明制得的手足癣药贴,每日2次,早晚各一次。
对照组:用温热水浸泡患处10分钟擦干后,于患处涂用萧氏皮肤外用药膏,每日2次,早晚各一次。
3、判断标准:
(1)显效:手足癣症状消失,无任何瘙痒、红斑、蜕皮等现象,患处皮肤恢复正常;
(2)有效:主要症状消失,患处皮肤尚未完全修复,有轻微遗留痕迹,;
(3)无效:手足癣症状无明显改善。
将对比试验后的数据进行记录,患处完全康复所用天数越少,相同时间内康复人数越多则药效越好。
4、试用结果:见表1。
表1
由表1记录的数据可知,本发明制备得到的手足癣药贴贴敷患处后,在三周内,患者的病症全部消失,患处皮肤恢复如初,而对照组中的药膏见效慢,且需要敷用治愈时间较长,且在后期长期的观察中发现,有些患者的手足癣患处还复发了相同病症。
二、典型案例:
王某,男,53岁,水产品养殖户,因需长期穿胶鞋下田地查看水产品,脚部常不透气,手部经常浸泡水,干完活后也不大注意清洗及透气护理,手部及脚部均感染真菌,患上手足癣,病史五年,贴敷本发明制得的手足癣药贴后,两周内手足癣基本痊愈,瘙痒感消失,红疹、蜕皮现象明显好转,继续贴敷一周后,完全治愈,皮肤恢复如初,且经下一年度内观察,并无复发症状。
李某,男,45岁,务农,脚部容易出汗,因经常穿着不透气的鞋子下地干活,一忙一整天,脚部不注意清洗及透气,患有足部脚癣,经常足部因受热出汗,瘙痒难耐,且蜕皮严重,脚丫处甚至有溃烂,贴敷本发明制得的手足癣药贴,10天左右,足癣有好转迹象,三周后痊愈,在下一年度内观察,并无复发症状。
胡某,男,29岁,厨师,因长期从事厨案工作,手部经常浸泡于水中,真菌感染导致手部患有手癣,有两年病史,涂敷本发明制备的手足癣药贴后,两周左右,手癣明显好转,三周内完全痊愈,无任何红疹斑痕存在,在下一年度内观察,并无复发症状。
袁某,37岁,女,普通工人,脚部因患有脚气,平时穿着的鞋子不透气,使足部患有足癣,病史六年,患处常伴有红点疙瘩、发白、烂脚丫,涂抹本产品制备的灰指甲药膏,三周后,足癣基本痊愈,一个月的时候,完全康复,且在下一年度内观察,无任何复发症状。
本发明的制备方法制得的手足癣药贴目前已经被附近群众所接受,尤其是多年患有手足癣久治不愈的患者,该手足癣药贴中的中药成分具有抑菌杀菌的作用,对多种致病的皮肤真菌都有很强的抑制作用,可治疗多种皮肤病,可有效抑制手足癣真菌的滋生;且具有攻毒杀虫止痒的功效,并且可加速透疹,使病理过程可以尽快消退;且该治疗过程简单,不需任何创伤,不会引发感染,仅需外用药贴,无任何副作用,见效快,且涂抹本发明药膏治愈后无复发,治疗对患者无局限性。
Claims (10)
1.一种手足癣药贴,其特征在于,包括以下原料组分:艾草、荆芥、生姜、菊花、蜂蜜、水杨酸、大枫子、硫磺、蝉蜕、全蝎和松香。
2.如权利要求1所述的手足癣药贴,其特征在于,所述原料组分的重量份数为:
3.如权利要求2所述的手足癣药贴,其特征在于,所述原料组分的重量份数为:
4.一种如权利要求1-3任一所述的手足癣药贴的制备方法,其特征在于,包括以下制备步骤:
1)称取艾草和菊花并混合粉碎处理,将碎末放入锅中用沸水煎煮,沸水煎煮2~3小时后,过滤,保留滤液;将滤液放入真空干燥箱中烘干处理,浓缩后得到药剂Ⅰ,备用;
2)称取荆芥并粉碎,倒入盛放有去离子水的三口烧瓶中,搅拌蒸馏,对馏出液离心处理,离心后静置,取上层油液,即得荆芥挥发油,备用;
3)将生姜、大枫子、蝉蜕和全蝎进行混合粉碎,粉碎成80~120目粉末,用温水浸泡3小时后,过滤;保留滤饼,并将滤饼放入烘箱中干燥处理,得到药剂Ⅱ;
4)将所述药剂Ⅰ和药剂Ⅱ混合,并向混合物中加入所述荆芥挥发油;水浴加热下,再向所述混合物中依次加入蜂蜜、水杨酸和硫磺,搅拌均匀后,保温静置24小时,得到目标药剂;
5)裁剪牛皮纸,并将松香放入坩埚中加热熔化,然后将所述目标药剂加入到松香中,搅拌均匀后,然后再将混合物涂覆于牛皮纸上,松香自然冷却后即得到手足癣药贴。
5.如权利要求4所述的手足癣药贴的制备方法,其特征在于,步骤1)中所述真空干燥箱的温度控制在75℃,压力控制在-0.1~-0.05MPa。
6.如权利要求4所述的手足癣药贴的制备方法,其特征在于,步骤2)中制得的所述荆芥挥发油需密闭、干燥存放。
7.如权利要求4所述的手足癣药贴的制备方法,其特征在于,步骤3)中所述温水的温度控制在45~55℃,所述烘箱内的温度控制在85℃。
8.如权利要求4所述的手足癣药贴的制备方法,其特征在于,步骤4)中所述水浴温度控制在50~55℃,并且所述水杨酸和硫磺按照质量比1:1配比。
9.如权利要求4所述的手足癣药贴的制备方法,其特征在于,步骤5)中将所述混合物涂覆于牛皮纸上,混合物涂覆的厚度不超过1mm。
10.如权利要求4所述的手足癣药贴的制备方法,其特征在于,步骤5)中制备好的所述手足癣药贴要放置于密闭、干燥、无菌的干燥器中保存。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810520185.7A CN108524886A (zh) | 2018-05-28 | 2018-05-28 | 一种手足癣药贴及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810520185.7A CN108524886A (zh) | 2018-05-28 | 2018-05-28 | 一种手足癣药贴及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108524886A true CN108524886A (zh) | 2018-09-14 |
Family
ID=63472858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810520185.7A Pending CN108524886A (zh) | 2018-05-28 | 2018-05-28 | 一种手足癣药贴及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108524886A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108355125A (zh) * | 2018-05-28 | 2018-08-03 | 陈雨薇 | 一种防皲裂药膏及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229336A (zh) * | 2008-01-15 | 2008-07-30 | 党喜 | 一种治疗顽癣的外用药 |
CN101810729A (zh) * | 2009-11-23 | 2010-08-25 | 王本善 | 一种治疗脚病的药物及其配制方法 |
CN102114151A (zh) * | 2010-06-23 | 2011-07-06 | 吕奎荣 | 一种治疗脚气的中药组方 |
-
2018
- 2018-05-28 CN CN201810520185.7A patent/CN108524886A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101229336A (zh) * | 2008-01-15 | 2008-07-30 | 党喜 | 一种治疗顽癣的外用药 |
CN101810729A (zh) * | 2009-11-23 | 2010-08-25 | 王本善 | 一种治疗脚病的药物及其配制方法 |
CN102114151A (zh) * | 2010-06-23 | 2011-07-06 | 吕奎荣 | 一种治疗脚气的中药组方 |
Non-Patent Citations (3)
Title |
---|
单耀辉: "中西药合用治疗手足癣151例观察", 《黑龙江中医药》 * |
国家中医药管理局专业技术资格考试专家委员会: "《全国中医药专业技术资格考试大纲与细则》", 30 November 2016, 中国中医药出版社 * |
林琼华: "常见病治疗验方两例", 《中国学校卫生》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108355125A (zh) * | 2018-05-28 | 2018-08-03 | 陈雨薇 | 一种防皲裂药膏及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100560124C (zh) | 一种治疗骨质增生症及疼痛的膏药及其制备方法 | |
CN102091203A (zh) | 一种治疗难愈性创面的外用中药制剂及其制备方法 | |
US20060269567A1 (en) | Universal detoxifying composition | |
CN101933970B (zh) | 治疗毒蛇咬伤的植物性药 | |
CN104857290A (zh) | 一种治疗烧烫伤的中药消毒膏及其制备方法 | |
CN101249186A (zh) | 一种兼治外伤、风湿痛、牙痛的中药油剂及其生产方法 | |
CN108524887A (zh) | 一种灰指甲药膏及其制备方法 | |
CN108379350A (zh) | 一种湿疹药膏及其制备方法 | |
CN108524886A (zh) | 一种手足癣药贴及其制备方法 | |
CN106620633A (zh) | 肿瘤患者用皮肤修护乳及其制作方法 | |
CN104825941A (zh) | 一种治疗脚气的中草药组合物及其制备方法 | |
CN104138499B (zh) | 一种治疗手足癣和甲癣的中药组合物、其制备方法及其应用 | |
CN111686188A (zh) | 一种清凉膏及其制备方法和应用方法 | |
CN111544419B (zh) | 冠心病外用贴膏及其贴膜 | |
CN107929372A (zh) | 治疗甲癣的中药组合物及其制备方法和用途 | |
CN107929624A (zh) | 一种治疗脚气的药膏及其制备方法 | |
CN105920189A (zh) | 一种治疗肝肾亏虚型足跟痛的中药组合物及其制备方法 | |
CN107050256A (zh) | 足部抗菌消炎凝胶及其制备方法 | |
CN106074813A (zh) | 一种治疗足跟痛的中药熏洗浸泡剂及其制备方法 | |
CN105998532A (zh) | 治疗气滞血瘀型足跟痛的中药制备方法及其组合物 | |
CN105709141A (zh) | 一种治疗手足癣的中药 | |
CN105125926A (zh) | 用于治疗烧烫伤的药粉及制备方法 | |
CN118903364A (zh) | 一种治疗糖尿病溃疡的中药组合物及其应用 | |
CN105168779A (zh) | 一种治疗皮肤过敏的药剂 | |
CN104069056A (zh) | 舒尔肤止痒水 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20180914 |